Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Specim is a Finland-based hyperspectral imaging company that develops and sells hyperspectral cameras, imaging spectrographs, software, and turnkey spectral imaging systems for industrial, research, airborne, and governmental users. The company is best known for its broad camera portfolio spanning visible, near-infrared, short-wave infrared, mid-wave infrared, and thermal ranges, as well as application-focused solutions for sorting, inspection, environmental monitoring, geology, food analysis, and life science research. Specim operates as part of the Konica Minolta Group following its 2020 acquisition by Konica Minolta Sensing Europe. Its products are commercialized globally from headquarters in Oulu, Finland, supported by international sales offices and distributor networks. Although its tools can be used in pharmaceutical and life science workflows, Specim is primarily an instrumentation and photonics company rather than a drug-development biotech or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Specim.